Analyst firms · Wolfe Research · IRTC
Wolfe Research IRTC price target and rating history
iRhythm Holdings Inc. (IRTC) · Health Care
Wolfe Research rates iRhythm Holdings Inc. (IRTC) Outperform with a $115 price target, as of its latest action on Jun 20, 2024. It has published 3 rating actions on IRTC since April 2022, including 2 upgrades and 0 downgrades. Across 4 firms with a IRTC price target in the last 12 months, the median target is $160.
- Current rating
- Outperform
- Price target
- $115
- Median target, all firms
- $160
- Actions on IRTC
- 3
Wolfe Research price target on IRTC
Every Wolfe Research rating on IRTC
- Jun 20, 2024
- Nov 7, 2022
- Apr 6, 2022
How other firms rate IRTC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Citigroup | Neutral | $124 | Nov 6, 2026 |
| Piper Sandler | Overweight | $160 | Oct 16, 2026 |
| Stephens | Overweight | $160 | Jul 23, 2026 |
| Evercore ISI | Outperform | $210 | Jan 5, 2026 |
Questions about Wolfe Research and IRTC
- What is Wolfe Research's price target for IRTC?
- Wolfe Research's latest stated price target for iRhythm Holdings Inc. (IRTC) is $115, from its action on Jun 20, 2024.
- What is Wolfe Research's rating on IRTC?
- Wolfe Research rates IRTC Outperform, a bullish rating, as of Jun 20, 2024.
- When did Wolfe Research last change its view on IRTC?
- On Jun 20, 2024, Wolfe Research upgrades to Outperform from Peer Perform, price target $115.
- How does Wolfe Research's IRTC target compare with other analysts?
- Across 4 firms with a IRTC price target in the last 12 months, the median target is $160.
More IRTC rating histories
All Wolfe Research ratingsIRTC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.